Aether Industries Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Aether Industries Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹642
Per ShareLot Size
23 Shares
Minimum Investment
₹14,766
Issue Size
₹799.02 Cr
Face Value
₹10
Per ShareIPO Type
Book Building
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Aether Industries Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
96.83%
Issue Type
Book Building
ISIN
INE0BWX01014
About the Company
Aether Industries Limited is a speciality chemical manufacturer in India producing advanced intermediates and speciality chemicals involving complex and differentiated chemistry and technology core competencies. Its business started in 2013, with a vision to create a niche in the global chemical industry. In its first phase through Fiscal 2017, the company focused on building its team and infrastructure and on its R&D centred around building its core competencies. Revenue generation commenced with its second phase in Fiscal 2018. The Company is one of the fastest growing specialty chemical companies in India, growing at CAGR of ~49.53% between Fiscals 2018 and 2021.
Industry Overview
From CY2020 to CY2025, the speciality chemical market is expected to grow globally by CAGR of 6.2% and in India by CAGR of 5.2%. This growth is expected to be led by sustained demand in end-use customer segments for its intermediate and speciality chemical products, which are experiencing consumption-led growth in India and key global markets. For example, from CY2020 to CY2025, agrochemicals and fertilizers speciality chemical segment in India is forecasted to grow from $32.9 billion to $53.3 billion, and the pharmaceuticals speciality chemical segment from $16.6 billion to $28.5 billion respectively.
Company History
Aether Industries Limited ("Company") was incorporated on January 23, 2013, at Surat, Gujarat, India as a public limited company under the Companies Act, 1956 and received the certificate for commencement of business from RoC on March 18, 2013.
Products & Services
- The Company is a speciality chemical manufacturer in India producing advanced intermediates and speciality chemicals involving complex and differentiated chemistry and technology core competencies.
Growth Strategy
- Leverage its strong position in the speciality chemicals industry to capitalize on industry opportunities
- Expand its Product Portfolio and diversify into additional business segments
- Expand Manufacturing, R&D and Pilot Plant Capacities
- Continue to strengthen its presence in India and expand its sales and distribution network in international markets
- Continue to focus on contract manufacturing / exclusive manufacturing by developing innovative processes and value engineering
- Growth through strategic acquisitions and alliances
Customer Base
Wholesalers and Retailers
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offer of 12,586,355** equity shares of face value of Rs. 10 each ("Equity Shares") of Aether Industries Limited ("Company" or "Issuer") for cash at a price of Rs. 642 per equity share (including a share premium of Rs. 632 per equity share)("Offer Price") aggregating to Rs. 808.04 crores** ("Offer") comprising a fresh issue of 9,766,355** equity shares aggregating to Rs. 627.00 crores* by the company (the "Fresh Issue") and an offer for sale of 2,820,000** equity shares by Purnima Ashwin Desai (the "Promoter Selling Shareholder") aggregating to Rs. 181.04 crores** ("Offer for Sale" and such equity shares, the "Offered Shares"). The offer includes a reservation of 111,370** equity shares, aggregating to Rs. 7.15 crores**, for subscription by eligible employees (as defined herein) (the "Employee Reservation Portion"). The employee reservation portion shall not exceed 0.09% of the post offer paid-up equity share capital the offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute 10.11% and 10.02%, respectively, of the post-offer paid-up equity share capital of the company. *The company, in consultation with the brlms, has undertaken a private placement of 2,024,921 equity shares aggregating to Rs. 130.00 crores ("pre-ipo placement"). The size of the fresh issue of equity shares has been adjusted pursuant to the pre-ipo placement. ** Subject to finalization of the basis of allotment The face value of the equity shares is Rs. 10 each. The offer price is 64.20 times the face value of the equity shares.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Differentiated portfolio of market-leading products
- Focus on R&D to leverage its core competencies of chemistry and technology
- Long standing relationships with a diversified customer base
- Synergistic Business Models focused on Large Scale Manufacturing, CRAMS and Contract Manufacturing
- Focus on Quality, Environment, Health and Safety (QEHS)
- Its business is dependent and will continue to depend on its manufacturing facilities, and its are subject to certain risks in its manufacturing process. Any slowdown or shutdown in its manufacturing operations or strikes, work stoppages or increased wage demands by its employees that could interfere with its operations could have an adverse effect on its business, financial condition and results of operations.
- The company is subject to certain risks consequent to its operations involving the manufacture, usage and storage of various hazardous substances.
- Its inability to successfully implement some or all its business strategies in a timely manner or at all could have an adverse effect on its business.
- The company derive a significant part of its revenue from major customers and its do not have long term contracts with all of these customers. If one or more of such customers choose not to source their requirements from its or to terminate its long-term contracts, its business, financial condition and results of operations may be adversely affected.
- Its reliance on certain industries for a significant portion of its sales could have an adverse effect on its business.